Items Tagged ‘Resverlogix’

March 8, 2010

Pfizer Cholesterol Flops Cleared Path for Resverlogix

By Kelley Luckstein

Resverlogix Corp., without a marketed product, may accomplish what Pfizer Inc., the world’s biggest drugmaker, couldn’t: Creating a new medicine that fights heart disease by raising so-called good cholesterol…   Resverlogix is banking that artificially raising HDL will have the same effect. Only one treatment now commercially available is marketed to increase good cholesterol. Niacin, […]

View full entry

Tags: cardiac events, cholesterol, Dr. Stephen Kopecky, Resverlogix